Mutant p53 in cancer: new functions and therapeutic opportunities

PAJ Muller, KH Vousden - Cancer cell, 2014 - cell.com
Many different types of cancer show a high incidence of TP53 mutations, leading to the
expression of mutant p53 proteins. There is growing evidence that these mutant p53s have …

Mutant p53: one name, many proteins

WA Freed-Pastor, C Prives - Genes & development, 2012 - genesdev.cshlp.org
There is now strong evidence that mutation not only abrogates p53 tumor-suppressive
functions, but in some instances can also endow mutant proteins with novel activities. Such …

RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues

K Yizhak, F Aguet, J Kim, JM Hess, K Kübler, J Grimsby… - Science, 2019 - science.org
INTRODUCTION Cancer genome studies have contributed to the analysis and discovery of
somatic mutations that drive cancer growth. However, studying the genetic makeup of a …

Role of p53 in cell death and human cancers

T Ozaki, A Nakagawara - Cancers, 2011 - mdpi.com
p53 is a nuclear transcription factor with a pro-apoptotic function. Since over 50% of human
cancers carry loss of function mutations in p53 gene, p53 has been considered to be one of …

Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors

M Canale, E Petracci, A Delmonte, E Chiadini… - Clinical Cancer …, 2017 - AACR
Purpose: To analyze the impact of TP53 mutations on response to first-line tyrosine kinase
inhibitors (TKI) in patients with EGFR-mutated non–small cell lung cancer (NSCLC) …

When mutants gain new powers: news from the mutant p53 field

R Brosh, V Rotter - Nature reviews cancer, 2009 - nature.com
Ample data indicate that mutant p53 proteins not only lose their tumour suppressive
functions, but also gain new abilities that promote tumorigenesis. Moreover, recent studies …

Mutant p53 gain-of-function in cancer

M Oren, V Rotter - Cold Spring Harbor perspectives in …, 2010 - cshperspectives.cshlp.org
In its wild-type form, p53 is a major tumor suppressor whose function is critical for protection
against cancer. Many human tumors carry missense mutations in the TP53 gene, encoding …

Dietary approaches to cancer therapy

M Tajan, KH Vousden - Cancer cell, 2020 - cell.com
The concept that dietary changes could improve the response to cancer therapy is extremely
attractive to many patients, who are highly motivated to take control of at least some aspect …

The rebel angel: mutant p53 as the driving oncogene in breast cancer

D Walerych, M Napoli, L Collavin, G Del Sal - Carcinogenesis, 2012 - academic.oup.com
Breast cancer is the most frequent invasive tumor diagnosed in women, causing over 400
000 deaths yearly worldwide. Like other tumors, it is a disease with a complex …

Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis

P Dong, M Karaayvaz, N Jia, M Kaneuchi, J Hamada… - Oncogene, 2013 - nature.com
The tumor suppressor gene p53 has been implicated in the regulation of epithelial–
mesenchymal transition (EMT) and tumor metastasis by regulating microRNA (miRNA) …